Jeremy Peters, is an Associate Scientist at Bristol-Myers Squibb Company. Working under Ravi Kalyanaraman, Ph.D., for the Global Analytical Technology group in Global Manufacturing and Supply, he is currently involved in product complaint testing and authentication, as well as developing new and novel techniques for Biological Drug Product Characterization and Structure determination. Prior to joining Global Analytical Technology, Jeremy worked at the Syracuse site of BMS where he was responsible for QC testing of Raw Materials used for Drug Substance batches. Jeremy received his BS in Chemical Engineering from the New Jersey Institute of Technology.